Treatments are usually administered over several weeks to gradually restore NAD+ levels while supporting metabolic balance
It works by enhancing insulin sensitivity and promoting glucose metabolism, which are key in controlling blood sugar levels and reducing body weight
Unlike full growth hormone therapy, it does not raise IGF1 (Insulin-like Growth Factor 1) and does not cause systemic growth effects
Laboratory monitoring, including renal function tests, may be recommended by your healthcare provider based on your individual risk factors and symptoms
Niazi notes that GLP-1s can also result in rare but serious side effects, including pancreatitis, gallbladder disease and cholecystitis
The medication is HSA and FSA eligible, offering additional ways to reduce out-of-pocket costs